CD19 and non-Hodgkin lymphoma: Our results further suggest that the unresponsiveness of R-NHL to anti-CD19 CAR CTL- and TRAIL-mediated killing is amenable to various small molecule sensitizing agents which have regulatory effects on apoptotic gene products; resistance could partially be rescued by SAHA, LBH589, and celecoxib.